Long noncoding RNA SLC9A3‑AS1 increases E2F6 expression by sponging microRNA‑486‑5p and thus facilitates the oncogenesis of nasopharyngeal carcinoma

Li,Jiansheng; Li,Dongzhi; Zhang,Xianhua; Li,Cuijuan; Zhu,Fengjuan

doi:10.3892/or.2021.8116

Long noncoding RNA SLC9A3‑AS1 increases E2F6 expression by sponging microRNA‑486‑5p and thus facilitates the oncogenesis of nasopharyngeal carcinoma

Authors:
- Jiansheng Li
- Dongzhi Li
- Xianhua Zhang
- Cuijuan Li
- Fengjuan Zhu
View Affiliations

Affiliations: Department of Otolaryngology, The People's Hospital of Rizhao, Rizhao, Shandong 276826, P.R. China
Published online on: June 17, 2021 https://doi.org/10.3892/or.2021.8116
Article Number: 165
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Long noncoding RNA SLC9A3 antisense RNA 1 (SLC9A3‑AS1) plays a central role in lung cancer; yet, its functions in nasopharyngeal carcinoma (NPC) have not been elucidated. The present study revealed the roles of SLC9A3‑AS1 in NPC and dissected the mechanisms downstream of SLC9A3‑AS1. SLC9A3‑AS1 levels in NPC were assessed by applying RT‑qPCR. The modulatory role of SLC9A3‑AS1 interference on NPC cells was examined using numerous functional experiments. High expression of SLC9A3‑AS1 was observed in NPC samples. Patients with NPC with a high level of SLC9A3‑AS1 experienced a shorter overall survival than those with a low SLC9A3‑AS1 level. Loss of SLC9A3‑AS1 reduced NPC cell proliferation, colony formation, migration, and invasion but induced cell apoptosis in vitro. Animal experiments further revealed that the depletion of SLC9A3‑AS1 hindered NPC tumour growth in vivo. As a competitive endogenous RNA, SLC9A3‑AS1 sponged microRNA‑486‑5p (miR‑486‑5p), consequently upregulating E2F transcription factor 6 (E2F6). Finally, the effects of SLC9A3‑AS1 silencing on NPC cells were reversed by inhibiting miR‑486‑5p or overexpressing E2F6. In summary, SLC9A3‑AS1 exerted carcinogenic effects on NPC cells by adjusting the miR‑486‑5p/E2F6 axis. Accordingly, the newly identified SLC9A3‑AS1/miR‑486‑5p/E2F6 pathway may offer attractive therapeutic targets for future development.

View Figures

View References

1	Chua ML, Wee JT, Hui EP and Chan AT: Nasopharyngeal carcinoma. Lancet. 387:1012–1024. 2016. View Article : Google Scholar : PubMed/NCBI
2	Lee AW, Ng WT, Chan YH, Sze H, Chan C and Lam TH: The battle against nasopharyngeal cancer. Radiother Oncol. 104:272–278. 2012. View Article : Google Scholar : PubMed/NCBI
3	Wei KR, Zheng RS, Zhang SW, Liang ZH, Ou ZX and Chen WQ: Nasopharyngeal carcinoma incidence and mortality in China in 2010. Chin J Cancer. 33:381–387. 2014.PubMed/NCBI
4	Lee AW, Tung SY, Ngan RK, Chappell R, Chua DT, Lu TX, Siu L, Tan T, Chan LK, Ng WT, et al: Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials. Eur J Cancer. 47:656–666. 2011. View Article : Google Scholar : PubMed/NCBI
5	Tan WL, Tan EH, Lim DW, Ng QS, Tan DS, Jain A and Ang MK: Advances in systemic treatment for nasopharyngeal carcinoma. Chin Clin Oncol. 5:212016. View Article : Google Scholar : PubMed/NCBI
6	Tao Q and Chan AT: Nasopharyngeal carcinoma: Molecular pathogenesis and therapeutic developments. Expert Rev Mol Med. 9:1–24. 2007. View Article : Google Scholar : PubMed/NCBI
7	Lam WK and Chan JY: Recent advances in the management of nasopharyngeal carcinoma. F1000Res. 7:F1000 Faculty Rev-1829. 2018. View Article : Google Scholar
8	Quinn JJ and Chang HY: Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 17:47–62. 2016. View Article : Google Scholar : PubMed/NCBI
9	Peng WX, Koirala P and Mo YY: LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
10	Spizzo R, Almeida MI, Colombatti A and Calin GA: Long non-coding RNAs and cancer: A new frontier of translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
11	Sanchez Calle A, Kawamura Y, Yamamoto Y, Takeshita F and Ochiya T: Emerging roles of long non-coding RNA in cancer. Cancer Sci. 109:2093–2100. 2018. View Article : Google Scholar : PubMed/NCBI
12	Liu C, Zhang H and Liu H: Long noncoding RNA UCA1 accelerates nasopharyngeal carcinoma cell progression by modulating miR-124-3p/ITGB1 axis. Onco Targets Ther. 12:8455–8466. 2019. View Article : Google Scholar : PubMed/NCBI
13	Zhong Q, Chen Y and Chen Z: LncRNA MINCR regulates irradiation resistance in nasopharyngeal carcinoma cells via the microRNA-223/ZEB1 axis. Cell Cycle. 19:53–66. 2020. View Article : Google Scholar : PubMed/NCBI
14	Zhao CX, Zhu W, Ba ZQ, Xu HJ, Liu WD, Zhu B, Wang L, Song YJ, Yuan S and Ren CP: The regulatory network of nasopharyngeal carcinoma metastasis with a focus on EBV, lncRNAs and miRNAs. Am J Cancer Res. 8:2185–2209. 2018.PubMed/NCBI
15	Guo H, Huang S, Li S, Yu H, Wu S and Zhou X: Prognostic significance of the long noncoding RNAs in nasopharyngeal carcinoma: A systematic review and meta-analysis. Cancer Manag Res. 10:1763–1779. 2018. View Article : Google Scholar : PubMed/NCBI
16	Liu H, Lei C, He Q, Pan Z, Xiao D and Tao Y: Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer. Mol Cancer. 17:642018. View Article : Google Scholar : PubMed/NCBI
17	Ji W, Sun B and Su C: Targeting microRNAs in cancer gene therapy. Genes (Basel). 8:212017. View Article : Google Scholar : PubMed/NCBI
18	Tian Y, Tang L, Yi P, Pan Q, Han Y, Shi Y, Rao S, Tan S, Xia L, Lin J, et al: MiRNAs in radiotherapy resistance of nasopharyngeal carcinoma. J Cancer. 11:3976–3985. 2020. View Article : Google Scholar : PubMed/NCBI
19	Wang S, Claret FX and Wu W: MicroRNAs as therapeutic targets in nasopharyngeal carcinoma. Front Oncol. 9:7562019. View Article : Google Scholar : PubMed/NCBI
20	Lee KT, Tan JK, Lam AK and Gan SY: MicroRNAs serving as potential biomarkers and therapeutic targets in nasopharyngeal carcinoma: A critical review. Crit Rev Oncol Hematol. 103:1–9. 2016. View Article : Google Scholar : PubMed/NCBI
21	Salmena L, Poliseno L, Tay Y, Kats L and Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
22	Bai Y, Qu Y, Wu Z, Ren Y, Cheng Z, Lu Y, Hu J, Lou J, Zhao J, Chen C and Mao H: Absolute quantification and analysis of extracellular vesicle lncRNAs from the peripheral blood of patients with lung cancer based on multi-colour fluorescence chip-based digital PCR. Biosens Bioelectron. 142:1115232019. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
24	Ghafouri-Fard S, Shoorei H, Anamag FT and Taheri M: The role of non-coding RNAs in controlling cell cycle related proteins in cancer cells. Front Oncol. 10:6089752020. View Article : Google Scholar : PubMed/NCBI
25	Qian Y, Shi L and Luo Z: Long Non-coding RNAs in cancer: Implications for diagnosis, prognosis, and therapy. Front Med. 7:6123932020. View Article : Google Scholar : PubMed/NCBI
26	McCabe EM and Rasmussen TP: LncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions. Semin Cancer Biol. Dec 17–2020.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
27	Zhao J, Liu D, Yang H, Yu S and He H: Long noncoding RNAs in head and neck squamous cell carcinoma: Biological functions and mechanisms. Mol Biol Rep. 47:8075–8090. 2020. View Article : Google Scholar : PubMed/NCBI
28	Wu J and Hann SS: Functions and roles of long-non-coding RNAs in human nasopharyngeal carcinoma. Cell Physiol Biochem. 45:1191–1204. 2018. View Article : Google Scholar : PubMed/NCBI
29	Dong Q, Zhou L, Liu F, Ao F, Gong X, Jiang C, Yuan Z and Li J: Long non-coding RNAs in the development, diagnosis and prognosis of nasopharyngeal carcinoma. Int J Clin Exp Pathol. 10:8098–8105. 2017.PubMed/NCBI
30	Xu J, Bai J, Zhang X, Lv Y, Gong Y, Liu L, Zhao H, Yu F, Ping Y, Zhang G, et al: A comprehensive overview of lncRNA annotation resources. Brief Bioinform. 18:236–249. 2017.PubMed/NCBI
31	Zhang K, Shi ZM, Chang YN, Hu ZM, Qi HX and Hong W: The ways of action of long non-coding RNAs in cytoplasm and nucleus. Gene. 547:1–9. 2014. View Article : Google Scholar : PubMed/NCBI
32	Rashid F, Shah A and Shan G: Long non-coding RNAs in the cytoplasm. Genomics Proteomics Bioinformatics. 14:73–80. 2016. View Article : Google Scholar : PubMed/NCBI
33	Lin L, Liu X and Lv B: Long non-coding RNA MEG3 promotes autophagy and apoptosis of nasopharyngeal carcinoma cells via PTEN up-regulation by binding to microRNA-21. J Cell Mol Med. 25:61–72. 2021. View Article : Google Scholar : PubMed/NCBI
34	Sen R, Ghosal S, Das S, Balti S and Chakrabarti J: Competing endogenous RNA: The key to posttranscriptional regulation. ScientificWorldJournal. 2014:8962062014. View Article : Google Scholar : PubMed/NCBI
35	Gao ZJ, Yuan WD, Yuan JQ, Yuan K and Wang Y: miR-486-5p functions as an oncogene by targeting PTEN in non-small cell lung cancer. Pathol Res Pract. 214:700–705. 2018. View Article : Google Scholar : PubMed/NCBI
36	Yang Y, Ji C, Guo S, Su X, Zhao X, Zhang S, Liu G, Qiu X, Zhang Q, Guo H and Chen H: The miR-486-5p plays a causative role in prostate cancer through negative regulation of multiple tumor suppressor pathways. Oncotarget. 8:72835–72846. 2017. View Article : Google Scholar : PubMed/NCBI
37	Xia L, Song M, Sun M, Chen W and Yang C: miR-486 promotes capan-2 pancreatic cancer cell proliferation by targeting phosphatase and tensin homolog deleted on chromosome 10 (PTEN). Front Genet. 10:5412019. View Article : Google Scholar : PubMed/NCBI
38	He M, Wang G, Jiang L, Qiu C, Li B, Wang J and Fu Y: miR-486 suppresses the development of osteosarcoma by regulating PKC-δ pathway. Int J Oncol. 50:1590–1600. 2017. View Article : Google Scholar : PubMed/NCBI
39	Liu C, Li M, Hu Y, Shi N, Yu H, Liu H and Lian H: miR-486-5p attenuates tumor growth and lymphangiogenesis by targeting neuropilin-2 in colorectal carcinoma. Onco Targets Ther. 9:2865–2871. 2016.PubMed/NCBI
40	Ma X, Wei J, Zhang L, Deng D, Liu L, Mei X, He X and Tian J: miR-486-5p inhibits cell growth of papillary thyroid carcinoma by targeting fibrillin-1. Biomed Pharmacother. 80:220–226. 2016. View Article : Google Scholar : PubMed/NCBI
41	An Y, Zhang J, Cheng X, Li B, Tian Y, Zhang X and Zhao F: miR-454 suppresses the proliferation and invasion of ovarian cancer by targeting E2F6. Cancer Cell Int. 20:2372020. View Article : Google Scholar : PubMed/NCBI
42	Cai Q, Zhao A, Ren LG, Chen J, Liao KS, Wang ZS and Zhang W: MiR-425 involves in the development and progression of renal cell carcinoma by inhibiting E2F6. Eur Rev Med Pharmacol Sci. 22:6300–6307. 2018.PubMed/NCBI
43	Lu Z, Nian Z, Jingjing Z, Tao L and Quan L: MicroRNA-424/E2F6 feedback loop modulates cell invasion, migration and EMT in endometrial carcinoma. Oncotarget. 8:114281–114291. 2017. View Article : Google Scholar : PubMed/NCBI